Albemarle — Nov 5, 2025 release

• Net loss of ($161) million, or ($1.72) per diluted share attributable to common shareholders; Adjusted loss of ($0.19) per diluted share attributable to common shareholders excludes a non-cash goodwill impairment charge associated with Ketjen. • Adjusted EBITDA of $226 million; up 7% due to improved fixed cost absorption and on-going cost savings. • On track to achieve full-year run-rate cost and productivity improvements of approximately $450 million, surpassing initial $300 to $400 million target. • Third quarter cash from operations of $356 million was up 57%, or $128 million ; year-to-date cash from operations of $894 million was also up 29%, or $202 million, due to cost and productivity i mprovements, cash management actions and a customer prepayment received in January. • Reducing full-year 2025 capital expenditures outlook to approximately $600 million. • Expect to achieve positive free cash flow (a) of $300 to $400 million for the full year 2025. • Enhancing full-year outlook considerations; enterprise results are expected to be towards the higher end of the previously published $9/kg scenario ranges given year-to-date financial performance and lithium market pricing and better-than-expected Energy Storage volumes. • On October 27, announced agreements to sell stakes in Ketjen and the Eurecat joint venture for combined pre-tax proceeds of approximately $660 million. “Our team delivered strong third quarter results, with adjusted EBITDA up year-over-year despite lower lithium prices, demonstrating the strength of our business and disciplined execution,” said Kent Masters, Chairman and CEO. “Our successful implementation